The triple transgenic (3×Tg-AD) AD mouse model that carries mutations in the amyloid precursor protein (APPswe), taup301L and presenilin 1PS1M146V exhibits amyloid peptide and tau pathology resembling the human AD brain [67,68]. This evidence concerns the gene MAPT and Alzheimer disease.